Dr. Yecheskel’s story: fitting her daughter with MiSight® 1 day to slow the progression of myopia

As an optometrist and a parent, Dr. Yecheskel is acutely aware of the increase in myopia prevalence in North America.¹ And, it's difficult to be an eye doctor who doesn't have an answer for parents concerned about their child's rapidly worsening myopia. It can be very frustrating when you try repeatedly to slow progression, but see the patient's prescription continuing to worsen.
With her own family history of high myopia, Dr. Yecheskel was vigilant about checking her twin daughters for any signs of myopia. When her first born, Daniella, began showing some of the classic symptoms around the age of 8, she had reason to act immediately. After all, 92% of Eye Care Professionals agree that it's important to help slow myopia progression at an early age (under 10 years old).²
When reviewing the myopia management options she might prescribe Daniella, Dr. Yecheskel knew she wanted a treatment option that provided her daughter with clear vision, while also helping to slow the progression of her myopia.†¹ That’s why she elected to fit Daniella with MiSight® 1 day soft contact lenses for age-appropriate children*.
As the very first patient at Dr. Yecheskel's practice to wear MiSight® 1 day, Daniella has now worn the lenses for two-and-a-half years and seen virtually no progression in her myopia.³±‡
Subscribe to our e-newsletter, ECP Viewpoints, to receive the latest updates in myopia management: coopervision.com/practitioner...
Subscribe for videos from MiSight® 1 day: bit.ly/Subscribe_MiSight
MiSight® 1 day on Facebook: / misightvision
MiSight® 1 day on Instagram: / misightvision
#MiSight #CooperVision #myopia
Indications and Important Safety Information
Rx only
Results may vary.
ATTENTION: Reference the Patient Information Booklet for a complete listing of Indications and Important Safety Information. *Indication: MiSight® 1 day (omafilcon A) soft (hydrophilic) contact lenses for daily wear are indicated for the correction of myopic ametropia and for slowing the progression of myopia in children with non-diseased eyes, who at the initiation of treatment are 8-12 years of age and have a refraction of -0.75 to -4.00 diopters(spherical equivalent) with ≤ 0.75 diopters of astigmatism. The lens is to be discarded after each removal. Warnings: Problems with contact lenses could result in serious injury to the eye. Do not expose contact lenses to water while wearing them. Under certain circumstances MiSight® lenses optical design can cause reduced image contrast/ghosting/halo/glare in some patients that may cause difficulties with certain visually demanding tasks. Precautions: Daily wear single use only. Patient should always dispose when lenses are removed. No overnight wear. Patients should exercise extra care if performing potentially hazardous activities. Adverse events: Including but not limited to infection/inflammation/ulceration/abrasion of the cornea, other parts of the eye or eyelids. Some of these adverse reactions can cause permanent or temporary loss of vision. If you notice any of the stated in your child, immediately have your child remove the lenses and contact your eye care professional.
†Compared to a single vision 1 day lens over a 3-year period.
± Children aged 8-12 at the initiation of treatment.
‡ No clinically meaningful change in refractive error -0.25D or less from baseline.
References:
1. Holden BA, Fricke TR, Wilson DA, et al. Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050. Ophthalmology. 2016;123(5):1036-1042. doi:10.1016/j.ophtha.2016.01.006
2. CVI data on file, 2019. Global survey by Decision Analyst with 402 ECPs in UK, Canada, Germany, Spain, Hong Kong, Australia/NZ. 92% agreed on a 1-10 point scale (top 4-box); early age (from 6 to 10 years old).
3. Chamberlain P, et al. A 3-year randomized clinical trial of MiSight® lenses for myopia control. Optom Vis Sci. 2019; 96(8):556-567